ascopubs.org

Single-Agent Versus Combination Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The Cancer and Leukemia Group B (study 9730)

Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer Group ...
ascopubs.org

Single-Agent Divarasib in Patients With KRAS G12C–Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study

Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers The primary objective of the study ...
Geeky Gadgets

Kimi K2 Agent Researcher for Deep Reasoning Research Tasks

What if you could delegate your most complex research tasks to an AI that not only understands the intricacies of your work but also evolves with every challenge it faces? Enter the Kimi K2 Agent ...
Forbes

Why CIOs Need Agent Orchestration To Scale AI Effectively

AI agents are now getting proficient at handling everyday tasks like incident response, access provisioning and service requests. A single AI agent solving a narrow problem is, indeed, helpful. But as ...
Morningstar

Marengo Late-Breaking Oral Presentation Highlights Single-Agent, Pan Tumor Activity of Invikafusp Alfa Across PD-1-Resistant Cancers in Phase 2 Clinical Trial at SITC 2025

CAMBRIDGE, Mass., Nov. 7, 2025 /PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering precision immunotherapies for oncology and inflammation & immunology (I&I), ...